HMOX1 and type 2 diabetes mellitus: In addition, enhanced Nrf2-dependent targets, such as GCLc, GCLm, GST, or HO-1, may act to counterbalance the cellular antioxidant profile in PBMCs, but not CD3+CD8+ cells, from T2D-PDT patients.